OverviewChartNewsTraderScreen

Soc. Generale Knock-Out SNW/  DE000CL7PR11  /

EUWAX
2024-05-20  9:08:36 AM Chg.-0.06 Bid10:00:43 PM Ask10:00:43 PM Underlying Strike price Expiration date Option type
2.10EUR -2.78% -
Bid Size: -		 -
Ask Size: -		 SANOFI SA INHABER ... 68.576 - 2078-12-31 Call
GlobeNewswire 05-20 Nurix Therapeutics Announces Board Chair Transition
GlobeNewswire 05-20 Dupixent® (dupilumab) Late-Breaking Data from NOTUS Confirmatory Phase 3 COPD Trial Presented at ATS...
GlobeNewswire 05-20 Press Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ...
GlobeNewswire 05-20 Shah Capital Withdraws Proxy Campaign Against Re-Election of Directors at Novavax’s 2024 Annual Meet...
GlobeNewswire 05-13 Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 20...
GlobeNewswire 05-13 Fulcrum Therapeutics Enters into a Collaboration and License Agreement with Sanofi for the Developme...
TeleTrader 05-13 Europe mixed at open as CPI prints loom
GlobeNewswire 05-13 Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chroni...
TeleTrader 05-10 Novavax skyrockets 213.5% in premarket, highest in 16 months
TeleTrader 05-10 Novavax soars 39.6% in premarket after Sanofi license deal
GlobeNewswire 05-10 Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVI...
GlobeNewswire 05-09 Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab
TeleTrader 05-09 Europe opens mixed with BoE in focus
GlobeNewswire 05-08 IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 05-07 Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
GlobeNewswire 05-02 Regeneron Reports First Quarter 2024 Financial and Operating Results
GlobeNewswire 05-02 Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant R...
GlobeNewswire 04-30 Press Release: Annual General Meeting of April 30, 2024
TeleTrader 04-25 Europe opens mostly down after corporate earnings
TeleTrader 04-25 Europe down in premarket as financial results pour in
TeleTrader 04-25 Sanofi books net sales of €10.5B in Q1, up 2.4%
GlobeNewswire 04-25 Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance
GlobeNewswire 04-23 Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia
GlobeNewswire 04-17 IGM Biosciences Announces Refocusing of Sanofi Collaboration
GlobeNewswire 04-17 Press Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in ...